Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Randomized, Parallel Group, Multiple Dose, 6-Week Study to Evaluate Safety, Tolerability, and Pharmacokinetics of Asenapine in Elderly Subjects With Psychosis.

NCT00281320 is registered in ClinicalTrials.gov with Organon and Co as lead sponsor.

NCT NCT00281320
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00281320 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Randomized, Parallel Group, Multiple Dose, 6-Week Study to Evaluate Safety, Tolerability, and Pharmacokinetics of Asenapine in Elderly Subjects With Psychosis.
Lead sponsor
Organon and Co
Phase
Phase 3
Overall status
Completed
Start date
February 28, 2006
Completion date
December 31, 2008
Enrollment
122 (actual)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

psychosis